Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | TLR4 | O00206 | 3/20 | 0.30 |
| ▸ | MGLL | Q99685 | 4/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL733349 | 0.84 | ALDH1A1 (0.36) | GLAALDH1A1 | |
| SCHEMBL6033533 | 0.81 | MGAM (0.43) | MGAMGAASIMGAM2GLA | |
| SCHEMBL28965160 | 0.81 | PAOX (0.31) | — | |
| SCHEMBL27743370 | 0.78 | GLA (0.31) | GLAMGLL | |
| SCHEMBL4618888 | 0.76 | GLA (0.32) | GLAMGLL | |
| SCHEMBL9724338 | 0.74 | SMN1; SMN2 (0.47) | MGLLALDH1A1MAPT | |
| SCHEMBL30779753 | 0.73 | GLA (0.41) | GLAMGLLALDH1A1 | |
| SCHEMBL30699 | 0.73 | GLA (0.41) | GLAMGLLALDH1A1 | |
| SCHEMBL18510166 | 0.73 | GLA (0.41) | GLAMGLLALDH1A1 | |
| SCHEMBL28381750 | 0.73 | PSMB8 (0.33) | GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115996942-A | Macrophage-targeting peptides, conjugates, compositions and uses thereof | 双亥生命科学株式会社 | 2023-04-21 | — | — | CN | claimed |
| EP-4103585-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | Twinpig Biolab, Inc. (KR) | 2022-12-21 | — | — | EP | claimed |
| US-20220354957-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | TWINPIG BIOLAB, INC. (KR) | 2022-11-10 | — | — | US | claimed |
| WO-2022234346-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | TWINPIG BIOLAB, INC. (KR) | 2022-11-10 | — | — | WO | claimed |
| US-11484601-B2 | Targeting M2-like tumor-associated macrophages by using melittin-based proapoptotic peptide | TWINPIGBIOLAB INC. (KR) | 2022-11-01 | — | — | US | claimed |
| US-20210244823-A1 | TARGETING M2-LIKE TUMOR-ASSOCIATED MACROPHAGES BY USING MELITTIN-BASED PROAPOPTOTIC PEPTIDE | TWINPIGBIOLAB INC. (KR) | 2021-08-12 | — | — | US | claimed |
| EP-3789041-A1 | TARGETING M2-LIKE TUMOR-ASSOCIATED MACROPHAGES BY USING MELITTIN-BASED PRO-APOPTOTIC PEPTIDE | Twinpigbiolab Inc. (KR) | 2021-03-10 | — | — | EP | claimed |
| US-10605810-B2 | Pincers comprising antibody and aptamer conjugated via a linker which binds to the same target material and use thereof | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2020-03-31 | — | — | US | claimed |
| EP-2906607-A2 | POLYMERS HAVING ORTHOGONAL REACTIVE GROUPS AND USES THEREOF | NVS Technologies Inc. (US) | 2015-08-19 | — | — | EP | claimed |
| EP-2478049-B1 | A POLYMER SUPPORT | UNIV CAPE TOWN (ZA) | 2015-02-25 | — | — | EP | claimed |
| WO-2007046865-A1 | BIOLOGICAL INDICATOR | STERIS, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| US-20060269983-A1 | Biological indicator | AMERICAN STERILIZER COMPANY | 2006-11-30 | — | — | US | claimed |
| WO-2006109311-A2 | ENZYME-CHANNELING BASED ELECTROCHEMICAL BIOSENSORS | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-10-19 | — | — | WO | claimed |
| WO-2006069366-A1 | METHODS OF PROTEIN PROFILING BY THIOLATION | INTEL CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| US-20060134694-A1 | Methods of protein profiling by thiolation | INTEL CORPORATION (US) | 2006-06-22 | — | — | US | claimed |
| EP-1506399-A2 | METHODS AND COMPOSITIONS FOR ANALYZING PROTEINS | Aclara BioSciences, Inc. (US) | 2005-02-16 | — | — | EP | claimed |
| US-20030013126-A1 | Methods and compositions for analyzing proteins | MONOGRAM BIOSCIENCES, INC. | 2003-01-16 | — | — | US | claimed |
| US-20020197649-A1 | Catalytic amplification of multiplexed assay signals | MONOGRAM BIOSCIENCES, INC. | 2002-12-26 | — | — | US | claimed |
| WO-2002097112-A2 | CATALYTIC AMPLIFICATION OF MULTIPLEXED ASSAY SIGNALS | ACLARA BIOSCIENCES, INC. (US) | 2002-12-05 | — | — | WO | claimed |
| WO-2002095356-A2 | METHODS AND COMPOSITIONS FOR ANALYZING PROTEINS | ACLARA BIOSCIENCES, INC. (US) | 2002-11-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10605810-B2 | Pincers comprising antibody and aptamer conjugated via a linker which binds to the same target material and use thereof | ILK, PAICS, AURKC | MGAM 3401/4885GAA 1675/4885SI 846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.